One potential explanation to reconcile their findings with ours is that the conditions they used to detect anti NHE3-P also detected total NHE3, which we observed to be increased with low-dose AngII and decreased during chronic AngII hypertension. This evidence concerns the gene SLC9A3 and hypertensive disorder.